Journal for ImmunoTherapy of Cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Journal for ImmunoTherapy of Cancer
Apr 26, 2024, 07:37 |
Blog
Meet the Author Amin H. Nassar by Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared on X/Twitter: "Meet the Author: Amin H. Nassar, a medical…
Apr 14, 2024, 07:51 |
Insight
New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach
Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach Published in Journal for ImmunoTherapy of Cancer,…
Feb 6, 2024, 16:25 |
Blog
Join us in congratulating Incoming Editor-in-Chief Michael Lotze and Deputy Editor-in-Chief Sjoerd van der Burg - Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared a post on LinkedIn: "Join us in congratulating Incoming…
Nov 22, 2023, 16:06 |
Blog
Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME
Shipra Gandhi, Translational Researcher at Roswell Park Comprehensive Cancer Center, shared a post by Journal…
Oct 8, 2023, 17:16 |
Blog
Sumanta K. Pal: I'm hugely indebted to Matt Galsky, not just for the chance to be a part of this Nature Medicine masterpiece he drove, but to see the joy of my pts doing well years out from chemo/IO without cystectomy.
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube